LISA GOMBITA: Open Payments
NPI 1437367109 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 13 payments from 6 companies in 2025. Trend: 2023 $394 · 2024 $448 · 2025 $734
Food & beverage: $666Education: $68
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $215 |
| Exelixis Inc. | 4 | $170 |
| Ipsen Biopharmaceuticals, Inc | 1 | $145 |
| Eisai Inc. | 1 | $95 |
| Novartis Pharmaceuticals Corporation | 2 | $65 |
| Celgene Corporation | 2 | $45 |
Products named: CABOMETYX, Onivyde, Lenvima, IMFINZI, PLUVICTO, SCEMBLIX, BREYANZI, REBLOZYL.
Industry payments across PA — which companies pay providers there.
